(Q36612270)

English

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy

scientific article published on August 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy (English)

1 reference

Europe PubMed Central

15 August 2017

chemoradiotherapy

0 references

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Sakano

1

1 reference

Europe PubMed Central

15 August 2017

T Wada

2

1 reference

Europe PubMed Central

15 August 2017

H Matsumoto

3

1 reference

Europe PubMed Central

15 August 2017

S Sugiyama

4

1 reference

Europe PubMed Central

15 August 2017

R Inoue

5

1 reference

Europe PubMed Central

15 August 2017

S Eguchi

6

1 reference

Europe PubMed Central

15 August 2017

H Ito

7

1 reference

Europe PubMed Central

15 August 2017

C Ohmi

8

1 reference

Europe PubMed Central

15 August 2017

H Matsuyama

9

1 reference

Europe PubMed Central

15 August 2017

K Naito

10

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 August 2006

1 reference

Europe PubMed Central

15 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

15 August 2017

95

1 reference

Europe PubMed Central

15 August 2017

561-570

1 reference

Europe PubMed Central

15 August 2017

5

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603290

0 references

Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Overview of bladder cancer trials in the Radiation Therapy Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Polymorphisms in DNA repair genes and associations with cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Genome maintenance mechanisms for preventing cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Bladder preservation in muscle-invasive bladder cancer by conservative surgery and radiochemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

DNA double-strand breaks: signaling, repair and the cancer connection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

XRCC1 keeps DNA from getting stranded

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

30 September 2017

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

28 June 2018

A single-nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle-invasive neoplasms of the urinary bladder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Polymorphisms in DNA repair and metabolic genes in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360681

20 September 2018

Single nucleotide polymorphisms in theXPGgene: Determination of role in DNA repair and breast cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603290

21 January 2018

Clinical course of bladder neoplasms and single nucleotide polymorphisms in theCDKN2Agene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603290

21 January 2018

Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603290

21 January 2018

Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Refined mapping of the three DNA repair genes, ERCC1, ERCC2, and XRCC1, on human chromosome 19

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

1 reference

https://pubmed.ncbi.nlm.nih.gov/16880786

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6603290

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36612270&oldid=1640701209"